Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

905
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
905
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.7K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.7K
Vaccinations01:51

Vaccinations

51.1K
Overview
51.1K
Development of Immunocompetence01:22

Development of Immunocompetence

745
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
745
Cancer Vaccines01:30

Cancer Vaccines

913
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
913
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exhausted CD4<sup>+</sup>T cells are associated with CCL4-driven immunosuppressive macrophage accumulation in enzootic bovine leukosis.

Frontiers in immunology·2026
Same author

Use of on-farm culturing for clinical mastitis treatment decisions and antimicrobial use in Argentina.

Revista Argentina de microbiologia·2026
Same author

Causes of culling in dairy cows in the central region of Santa Fe, Argentina.

The Journal of dairy research·2026
Same author

Experimental assessment of AI-based interactome mapping.

Nature communications·2026
Same author

MafB is a conserved transcriptional regulator of macrophage development and functional identity across tissues and species.

Immunity·2026
Same author

A scalable approach to resolving variants of uncertain significance.

bioRxiv : the preprint server for biology·2026

Related Experiment Video

Updated: Jan 6, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.7K

BLV: lessons on vaccine development.

Alejandro Abdala1, Irene Alvarez2, Hélène Brossel3

  • 1Estacion Experimental Agropecuaria Rafaela, INTA, 2300, Rafaela, Argentina.

Retrovirology
|October 9, 2019
PubMed
Summary
This summary is machine-generated.

Developing effective vaccines against retroviruses like bovine leukemia virus (BLV) is difficult due to viral latency and integration. This review examines challenges and strategies for creating safe and effective BLV vaccines.

Keywords:
BLVHTLVLeukemiaRetrovirusVaccine

More Related Videos

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.0K

Related Experiment Videos

Last Updated: Jan 6, 2026

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.7K
Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay
05:15

Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle VLP-Based Vaccines Using a Capture Assay

Published on: February 10, 2022

4.1K
Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes
08:27

Synthesis and Characterization of mRNA-Loaded PolyBeta Aminoesters Nanoparticles for Vaccination Purposes

Published on: August 13, 2021

5.0K

Area of Science:

  • Veterinary immunology
  • Retroviral vaccine development
  • Bovine leukemia virus (BLV) research

Background:

  • Retroviruses, including BLV, pose vaccination challenges due to genomic integration and immune evasion.
  • Established BLV infections are difficult to clear, necessitating sterilizing immunity through vaccination.
  • Vaccine-associated risks include increased infection susceptibility and pathogen reversion.

Purpose of the Study:

  • To review the challenges in developing an efficient vaccine against bovine leukemia virus (BLV).
  • To analyze historical vaccine failures and current vaccine candidate efficacy and safety.
  • To discuss economic factors influencing industrial vaccine development.

Main Methods:

  • Review of historical data on inactivated BLV vaccines.
  • Evaluation of efficacy and safety studies on live-attenuated BLV vaccine candidates.
  • Analysis of economic feasibility for large-scale vaccine production.

Main Results:

  • Inactivated BLV vaccines have historically failed to provide adequate protection.
  • Live-attenuated vaccines show promise in terms of efficacy and safety but face development hurdles.
  • Economic constraints significantly impact the industrialization of new BLV vaccines.

Conclusions:

  • Developing a successful BLV vaccine requires overcoming challenges related to viral latency and immune escape.
  • Live-attenuated vaccines represent a potential strategy, but further research and development are crucial.
  • Economic viability is a critical consideration for the successful commercialization of BLV vaccines.